Xeris Biopharma
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Xeris Biopharma
Xeris Biopharma Holdings, Inc. 成立於2005年，依據特拉華州法律註冊。公司致力於打造一家創新且自我維持的成長型生物製藥企業，專注於開發並商業化一系列具有臨床意義的新療法，旨在提升患者生活品質。憑藉三款商業化產品及專有配方技術（包括 XeriSol 與 XeriJect），Xeris Biopharma 不僅建立了穩固的合作夥伴關係，也持續強化候選藥物的競爭力。公司官網：http://www.xerispharma.com 公司地址：180 N. LaSalle Street Suite 1300 Chicago, Illinois 60607
如何購買 Xeris Biopharma (XERS)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 XERS
透過 RockFlow App 或網頁端搜尋 XERS，輸入您想要投資的金額，然後點擊確認即可完成交易。
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.